Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases

por Liepe, K, Kropp, J, Runge, R, Kotzerke, J
Publicado 2003

Impact of staging with (18)F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors

por Eschmann, S. M., Friedel, G., Paulsen, F., Reimold, M., Hehr, T., Scheiderbauer, J., Budach, W., Kotzerke, J., Bares, R.
Publicado 2006

Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma

por Naumann, R, Beuthien-Baumann, B, Reiß, A, Schulze, J, Hänel, A, Bredow, J, Kühnel, G, Kropp, J, Hänel, M, Laniado, M, Kotzerke, J, Ehninger, G
Publicado 2004

Overestimation of grey matter atrophy in glioblastoma patients following radio(chemo)therapy

por Gommlich, A., Raschke, F., Petr, J., Seidlitz, A., Jentsch, C., Platzek, I., van den Hoff, J., Kotzerke, J., Beuthien-Baumann, B., Baumann, M., Krause, M., Troost, E. G. C.
Publicado 2021

Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy

por Raschke, F., Witzmann, K., Seidlitz, A., Wesemann, T., Jentsch, C., Platzek, I., van den Hoff, J., Kotzerke, J., Beuthien-Baumann, B., Baumann, M., Linn, J., Krause, M., Troost, E.G.C.
Publicado 2022